In last trading session, Relay Therapeutics Inc (NASDAQ:RLAY) saw 1.17 million shares changing hands with its beta currently measuring 1.61. Company’s recent per share price level of $4.09 trading at -$0.07 or -1.68% at ring of the bell on the day assigns it a market valuation of $684.59M. That closing price of RLAY’s stock is at a discount of -170.66% from its 52-week high price of $11.07 and is indicating a premium of 14.43% from its 52-week low price of $3.50.
For Relay Therapeutics Inc (RLAY), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.09. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Relay Therapeutics Inc (NASDAQ:RLAY) trade information
Upright in the red during last session for losing -1.68%, in the last five days RLAY remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $4.09 price level, adding 3.54% to its value on the day. Relay Therapeutics Inc’s shares saw a change of -0.73% in year-to-date performance and have moved 8.78% in past 5-day. Relay Therapeutics Inc (NASDAQ:RLAY) showed a performance of -12.23% in past 30-days.
Wall Street analysts have assigned a consensus price target of 18 to the stock, which implies a rise of 77.28% to its current value. Analysts have been projecting 16 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -291.2% in reaching the projected high whereas dropping to the targeted low would mean a loss of -291.2% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -38.74% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 9.43% while estimates for its earnings growth in next 5 years are of 1.60%.
Relay Therapeutics Inc (NASDAQ:RLAY)’s Major holders
SB INVESTMENT ADVISERS (UK) LTD is the top institutional holder at RLAY for having 27.9 million shares of worth $181.94 million. And as of 2024-06-30, it was holding 21.0093 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 11.7 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8125 of outstanding shares, having a total worth of $76.32 million.
